ATE435870T1 - Aus ll-37 abgeleiteten peptidinhibitoren von toxinen - Google Patents

Aus ll-37 abgeleiteten peptidinhibitoren von toxinen

Info

Publication number
ATE435870T1
ATE435870T1 AT04705556T AT04705556T ATE435870T1 AT E435870 T1 ATE435870 T1 AT E435870T1 AT 04705556 T AT04705556 T AT 04705556T AT 04705556 T AT04705556 T AT 04705556T AT E435870 T1 ATE435870 T1 AT E435870T1
Authority
AT
Austria
Prior art keywords
terminal part
amino acid
peptide inhibitors
toxins derived
sequence
Prior art date
Application number
AT04705556T
Other languages
English (en)
Inventor
Johannes Grote
Jan Drijfhout
Original Assignee
Academisch Ziekenhuis Leiden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Academisch Ziekenhuis Leiden filed Critical Academisch Ziekenhuis Leiden
Application granted granted Critical
Publication of ATE435870T1 publication Critical patent/ATE435870T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723Cationic antimicrobial peptides, e.g. defensins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04705556T 2003-01-28 2004-01-27 Aus ll-37 abgeleiteten peptidinhibitoren von toxinen ATE435870T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03075274 2003-01-28
PCT/NL2004/000060 WO2004067563A1 (en) 2003-01-28 2004-01-27 Peptide inhibitors of toxins derived from ll-37

Publications (1)

Publication Number Publication Date
ATE435870T1 true ATE435870T1 (de) 2009-07-15

Family

ID=32798944

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04705556T ATE435870T1 (de) 2003-01-28 2004-01-27 Aus ll-37 abgeleiteten peptidinhibitoren von toxinen

Country Status (19)

Country Link
US (1) US7807617B2 (de)
EP (1) EP1587830B1 (de)
JP (1) JP4471968B2 (de)
KR (1) KR100856819B1 (de)
CN (1) CN1798764B (de)
AT (1) ATE435870T1 (de)
AU (1) AU2004207118B2 (de)
BR (1) BRPI0407022A (de)
CA (1) CA2514584C (de)
CR (1) CR7926A (de)
DE (1) DE602004021901D1 (de)
DK (1) DK1587830T3 (de)
ES (1) ES2328571T3 (de)
MX (1) MXPA05008080A (de)
NZ (1) NZ541657A (de)
PT (1) PT1587830E (de)
RU (1) RU2346950C2 (de)
WO (1) WO2004067563A1 (de)
ZA (1) ZA200506411B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1621205A1 (de) * 2004-07-28 2006-02-01 OctoPlus Technologies B.V. CAP18 ähnliche Peptide mit antibiotischer Wirkung
US7465784B2 (en) * 2006-10-26 2008-12-16 Board Of Regents Of The University Of Nebraska Antimicrobial peptides and methods of identifying the same
WO2009015336A2 (en) 2007-07-25 2009-01-29 Biolex Therapeutics, Inc. Controlled release interferon drug products and treatment of hcv infection using same
EP2538964A4 (de) * 2010-02-25 2013-07-31 Univ Manitoba Modulation von cytokininduzierten chronischen entzündungsreaktionen
US10723764B2 (en) 2011-11-21 2020-07-28 Board Of Regents Of The University Of Nebraska Anti-microbial peptides and methods of use thereof
US9580472B2 (en) 2011-11-21 2017-02-28 Board Of Regents Of The University Of Nebraska Anti-microbial peptides and methods of use thereof
AR092872A1 (es) * 2012-09-17 2015-05-06 Madrigal Pharmaceuticals Inc Metodo para sintetizar analogos de la hormona tiroidea y polimorfos de los mismos
BR112017009764A2 (pt) 2014-11-10 2018-02-20 Hoffmann La Roche anticorpos biespecíficos e métodos de uso em oftalmologia
RU2584089C1 (ru) * 2015-06-15 2016-05-20 Государственное Бюджетное Образовательное Учреждение Высшего Профессионального Образования "Саратовский Государственный Медицинский Университет Имени В.И. Разумовского" Министерства Здравоохранения Российской Федерации Способ снижения летального эффекта бактериального липополисахарида in vitro
CN105859867A (zh) * 2016-05-30 2016-08-17 黄石市中心医院 一种人源抗菌肽ll-37突变体及其应用
CN108892719B (zh) * 2018-07-09 2021-07-30 珠海中科先进技术研究院有限公司 一种新型人源抗菌肽ll-37衍生物及其应用
WO2021143745A1 (zh) * 2020-01-14 2021-07-22 中国科学院上海药物研究所 一种长效罗哌卡因药物组合物及其制备方法和用途
CN113116811A (zh) * 2020-01-14 2021-07-16 中国科学院上海药物研究所 可注射长效镇痛药物组合物及其制备方法和用途
WO2024223883A1 (en) 2023-04-26 2024-10-31 Karl-Franzens-Universität Graz Peptides for cancer therapy
WO2024223887A1 (en) 2023-04-26 2024-10-31 Karl-Franzens-Universität Graz Peptides for antimicrobial therapy
CN118754950B (zh) * 2024-06-07 2025-03-07 扬州大学 一种抗菌衍生肽及其组合物和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103888A (en) * 1992-07-17 2000-08-15 Panorama Research, Inc. Mammalian cationic proteins having lipopolysaccharide binding and anti-coagulant activity
US5681824A (en) * 1995-06-05 1997-10-28 Eisai Co., Ltd. Substituted liposaccharides useful in the treatment and prevention of endotoxemia
JP4037525B2 (ja) * 1998-03-25 2008-01-23 生化学工業株式会社 新規抗菌性ペプチド

Also Published As

Publication number Publication date
RU2005127076A (ru) 2006-01-20
JP2007528696A (ja) 2007-10-18
WO2004067563A1 (en) 2004-08-12
BRPI0407022A (pt) 2006-01-10
ES2328571T3 (es) 2009-11-16
WO2004067563A8 (en) 2004-12-02
AU2004207118A1 (en) 2004-08-12
CA2514584C (en) 2012-05-29
US20060223755A1 (en) 2006-10-05
PT1587830E (pt) 2009-09-23
RU2346950C2 (ru) 2009-02-20
DK1587830T3 (da) 2009-10-26
JP4471968B2 (ja) 2010-06-02
US7807617B2 (en) 2010-10-05
KR100856819B1 (ko) 2008-09-05
MXPA05008080A (es) 2006-02-08
HK1088613A1 (zh) 2006-11-10
NZ541657A (en) 2009-01-31
CR7926A (es) 2006-02-07
DE602004021901D1 (de) 2009-08-20
AU2004207118B2 (en) 2009-12-17
EP1587830B1 (de) 2009-07-08
CN1798764B (zh) 2010-05-12
ZA200506411B (en) 2006-04-26
CA2514584A1 (en) 2004-08-12
KR20060012261A (ko) 2006-02-07
EP1587830A1 (de) 2005-10-26
CN1798764A (zh) 2006-07-05

Similar Documents

Publication Publication Date Title
ATE435870T1 (de) Aus ll-37 abgeleiteten peptidinhibitoren von toxinen
ATE387629T1 (de) Gemeinsame epitope von antigenen aus einer multigen-familie
IN2014CN02050A (de)
WO2004014940A3 (en) PEPTIDES AS SOLUBILIZING EXCIPIENTS FOR TRANSFORMING GROWTH FACTOR ß PROTEINS
NO20063026L (no) Antistoffer
ATE457737T1 (de) Polypeptide zur induktion einer schützenden immunantwort gegen staphylococcus aureus
ATE368053T1 (de) Antimikrobielle peptide
EA200700973A1 (ru) Слитый белок, содержащий домен bh3 белка «вh3-только»
DE60335726D1 (de) Chromoprotein und fluoroproteine
WO2006054262A3 (en) Use of phage display technique for identifying peptides capable of binding progenitor/stem cells, peptides thereby obtained and uses thereof
CY1111630T1 (el) Παραγωγα κυτοκινων
ATE280827T1 (de) Penaeidine: antimikrobielle peptide aus krebstieren
ATE256147T1 (de) Peptide gegen pilzen
ATE323763T1 (de) Dna & protein bindende miniatur proteine
DE602004028266D1 (de) Angiogene peptide und ihre verwendungen
WO2005044845A3 (en) Protein binding miniature proteins
ES2557938T3 (es) Antagonistas de resistina y su uso
EA200601408A1 (ru) Композиция, способы и применения нового семейства пептидов
EA200702012A1 (ru) Пептиды механо-фактора роста и их применение
CO7220324A2 (es) Polipeptidos relacionados con toxina con actividad microbiana y antiviral
WO2003057708A3 (en) Fusion proteins
WO2007058267A8 (ja) 新規タンパク質及びそれをコードする遺伝子
NZ596259A (en) Biologically produced cyclic affinity tags comprising cyclized streptavidin binding sequence
MX2024004272A (es) Nueva proteina de polen de junipero.
ATE466876T1 (de) Immunogene konstrukte

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1587830

Country of ref document: EP